Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disease affecting 15–25 % of the general population. Aims The aim of this study was to investigate the prevalence of NAFLD and the relationship between insulin sensitivity and NAFLD in grade III high and very high cardiovascular additional risk essential hypertensive patients according to the circadian blood pressure (BP) rhythm. Method This four-year prospective study was conducted at the Department of Internal Medicine at Cluj-Napoca’s Diagnosis and Treatment Centre in Romania. The study included grade III essential hypertensive patients. Hypertensive patients were divided into four groups according to the diurnal index (DI) from ABPM monitoring: dipper (D), non...
Patients with fatty liver (FL) disease have a high risk of developing diabetes and cardiovascular di...
Backgroun: Type 2 diabetes mellitus (T2DM) and Nonalcoholic fatty liver disease (NAFLD) have risen g...
Although non-alcoholic fatty liver disease is the hepatic manifestation of metabolic syndrome, its i...
OBJECTIVE: The pathogenesis of nonalcoholic fatty liver disease (NAFLD) is multifactorial, and the p...
OBJECTIVE: The pathogenesis of nonalcoholic fatty liver disease (NAFLD) is multifactorial, and the ...
Background and aim: Insulin resistance is recognized as the pathophysiological hallmark of non-alcoh...
BACKGROUND AND AIM: Insulin resistance is recognized as the pathophysiological hallmark of non-alcoh...
Abstract BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) has been found to be strongly...
AbstractBackgroundThere is increasing recognition of association of nonalcoholic fatty liver disease...
SummaryBackground/purposeNonalcoholic fatty liver disease (NAFLD) is a common condition comprising a...
Abstract. Background:. There is little published evidence about the role of non-alcoholic fatty live...
The prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing rapidly worldwide, af...
BACKGROUND: The conditions associated with fatty liver disease presenting with normal liver enzymes ...
Although non-alcoholic fatty liver disease is the hepatic manifestation of metabolic syndrome, its i...
Background: There is increasing recognition of association of nonalcoholic fatty liver disease (NAFL...
Patients with fatty liver (FL) disease have a high risk of developing diabetes and cardiovascular di...
Backgroun: Type 2 diabetes mellitus (T2DM) and Nonalcoholic fatty liver disease (NAFLD) have risen g...
Although non-alcoholic fatty liver disease is the hepatic manifestation of metabolic syndrome, its i...
OBJECTIVE: The pathogenesis of nonalcoholic fatty liver disease (NAFLD) is multifactorial, and the p...
OBJECTIVE: The pathogenesis of nonalcoholic fatty liver disease (NAFLD) is multifactorial, and the ...
Background and aim: Insulin resistance is recognized as the pathophysiological hallmark of non-alcoh...
BACKGROUND AND AIM: Insulin resistance is recognized as the pathophysiological hallmark of non-alcoh...
Abstract BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) has been found to be strongly...
AbstractBackgroundThere is increasing recognition of association of nonalcoholic fatty liver disease...
SummaryBackground/purposeNonalcoholic fatty liver disease (NAFLD) is a common condition comprising a...
Abstract. Background:. There is little published evidence about the role of non-alcoholic fatty live...
The prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing rapidly worldwide, af...
BACKGROUND: The conditions associated with fatty liver disease presenting with normal liver enzymes ...
Although non-alcoholic fatty liver disease is the hepatic manifestation of metabolic syndrome, its i...
Background: There is increasing recognition of association of nonalcoholic fatty liver disease (NAFL...
Patients with fatty liver (FL) disease have a high risk of developing diabetes and cardiovascular di...
Backgroun: Type 2 diabetes mellitus (T2DM) and Nonalcoholic fatty liver disease (NAFLD) have risen g...
Although non-alcoholic fatty liver disease is the hepatic manifestation of metabolic syndrome, its i...